Literature DB >> 7491952

Mucin gene structure and expression: protection vs. adhesion.

B J Van Klinken1, J Dekker, H A Büller, A W Einerhand.   

Abstract

The cloning of mucin cDNAs brought about by the application of molecular biology and molecular analyses constitutes a major step in understanding mucin structure and function. Here two classes of mucins are described: epithelium-associated and endothelium/leukocyte-associated mucins, which have thus far been described separately in the literature. The epithelial mucins are generally believed to play a role in cytoprotection. The endothelial and leukocyte class of mucins are adhesion molecules involved in lymphocyte homing and lymphocyte activation or are part of the adhesion cascade that plays a role in the initiation of inflammation. Mucins in general contain many threonine and serine residues, which are extensively O-glycosylated. Due to this profound glycosylation, mucins have a filamentous conformation. By virtue of their extended filamentous, and often negatively charged, structure, mucins can act as a barrier protecting the cell. However, when an opposing cell has specific receptors for mucins, adhesion can override the barrier function. Therefore, mucins may be powerful two-edged swords: they are both protective and adhesive.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491952     DOI: 10.1152/ajpgi.1995.269.5.G613

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  86 in total

1.  Alterations in gastric mucin synthesis by Helicobacter pylori.

Authors:  James C Byrd; Robert S Bresalier
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast.

Authors:  Y N Lee; J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 3.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

4.  Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression.

Authors:  Michael D Cleary; Upinder Singh; Ira J Blader; Jeremy L Brewer; John C Boothroyd
Journal:  Eukaryot Cell       Date:  2002-06

5.  Fate of goblet cells in experimental colitis.

Authors:  Mireille K Makkink; Nicole M J Schwerbrock; Michael Mähler; Jos A Boshuizen; Ingrid B Renes; Markus Cornberg; Hans J Hedrich; Alexandra W C Einerhand; Hans A Büller; Siegfried Wagner; Marie-Luise Enss; Jan Dekker
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 6.  [Tear outflow. Impact of mucins and TFF-peptides].

Authors:  F Paulsen; A Corfield; M Hinz; W Hoffmann; U Schaudig; A Thale; M Berry
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

7.  A cell surface mucin specifically expressed in the midgut of the malaria mosquito Anopheles gambiae.

Authors:  Z Shen; G Dimopoulos; F C Kafatos; M Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

9.  A novel method to determine small intestinal barrier function in human neonates in vivo.

Authors:  M W Schaart; H Schierbeek; A C J M de Bruijn; D Tibboel; J B van Goudoever; I B Renes
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

10.  The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth.

Authors:  David K Rhee; Jose Marcelino; MacArthur Baker; Yaoqin Gong; Patrick Smits; Véronique Lefebvre; Gregory D Jay; Matthew Stewart; Hongwei Wang; Matthew L Warman; John D Carpten
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.